ClinicalTrials.gov
ClinicalTrials.gov Menu

Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01349088
Recruitment Status : Withdrawn
First Posted : May 6, 2011
Last Update Posted : October 21, 2016
Sponsor:
Collaborators:
Susan G. Komen Breast Cancer Foundation
Amgen
Information provided by (Responsible Party):
Thomas Jefferson University ( Sidney Kimmel Cancer Center at Thomas Jefferson University )

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : September 2015
  Estimated Study Completion Date : September 2018